Copyright: ©Author(s) 2026.
World J Clin Pediatr. Jun 9, 2026; 15(2): 119843
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.119843
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.119843
Table 3 Standardized acute pharmacotherapy: Weight-based dosing
| Agent | Pediatric dose (mg/kg) | Max single dose | Monthly limit | Monitoring/safety |
| Ibuprofen | 10 mg/kg | 800 mg | < 14 days/month | Take with food; avoid in active gastritis or renal impairment |
| Acetaminophen | 15 mg/kg | 1000 mg | < 14 days/month | Hepatic safety; check for “hidden” sources in OTC products |
| Naproxen | 5-10 mg/kg | 500 mg | < 14 days/month | Preferred for long-duration attacks due to 12 hours half-life |
| Sumatriptan | Nasal spray: 5-20 mg | 20 mg | < 9 days/month | Monitor for “triptan sensations” (chest/neck tightness) |
- Citation: Al-Beltagi M. Pediatric migraine: Neurodevelopmental mechanisms, clinical phenotypes, and modern therapeutics. World J Clin Pediatr 2026; 15(2): 119843
- URL: https://www.wjgnet.com/2219-2808/full/v15/i2/119843.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v15.i2.119843